Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus
TheFly reported on April 8 that Morgan Stanley reduced its price target on BCYC to $12 from $13 while maintaining an Equal Weight rating.
Bicycle Therapeutics Plc (BCYC)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 10,885,357 | $50,508,056 | 0.29% | |
| 2. | Armistice Capital Steven Boyd | 3,398,000 | $15,766,720 | +6% | 0.28% |
| 3. | Long Focus Capital Management John B. Helmers | 3,310,687 | $15,361,588 | +103% | 0.4% |
| 4. | Siren L.L.C. Raymond Debbane | 1,560,882 | $7,242,492 | -23% | 0.2% |
| 5. | Renaissance Technologies Jim Simons | 979,300 | $4,543,952 | +73% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.34 | 457,631 | $7,020,883.28 | 9,995,274 | 2024-12-16 | Filing | |
| $15.34 | 42,369 | $650,016.72 | 914,083 | 2024-12-16 | Filing | |
| $13.80 | 566,814 | $7,824,300.46 | 9,537,643 | 2024-12-13 | Filing | |
| $13.80 | 52,656 | $726,863.42 | 871,714 | 2024-12-13 | Filing | |
| $13.72 | 244,587 | $3,356,760.91 | 8,970,829 | 2024-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.34 | 333 | $1,445.22 | 91,052 | 2026-07-06 | Filing | |
| $4.31 | 43 | $185.33 | 91,385 | 2026-07-06 | Filing | |
| $4.27 | 1,036 | $4,423.72 | 91,428 | 2026-07-02 | Filing | |
| $4.31 | 532 | $2,292.92 | 157,171 | 2026-07-06 | Filing | |
| $4.27 | 1,859 | $7,937.93 | 157,703 | 2026-07-02 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,704 | $32,665 | 0% | |
| 2. | 26,250 | $111 | 0.04% |
News See All
10 Best Biotech Stocks Under $10 to Buy
According to Eli Casdin, CEO of Casdin Capital, biotech is currently experiencing a momentary stop despite being in one of the best economic environments in years.
7 Fastest Growing European Stocks to Invest In
European stocks are getting a closer look again, and not only because investors want to diversify away from a crowded U.S. trade.
Bicycle Therapeutics (BCYC) Appoints Travis Thompson as CFO Following Leadership Transitions
Bicycle Therapeutics (NASDAQ:BCYC) is one of the best get-rich-quick stocks to buy according to hedge funds.
12 Best Get Rich Quick Stocks to Buy According to Hedge Funds
On March 9, Main Management CEO and Portfolio Manager Kim Arthur joined CNBC’s ‘Halftime Report’ to talk about what he’s seeing in his sector rotation fund, and whether the volatility is exacerbating...
Top 10 Stocks Under $10 That Could Triple
The Bureau of Labor Statistics reported that only 22,000 jobs were added in August, much less than the 75,000 jobs that economists polled by Dow Jones had expected.
Top 11 Small Cap Stocks to Buy with Biggest Upside Potential
On April 24, Jill Carey Hall, BofA Securities head of U.S. small/mid-cap strategy, appeared on 'Closing Bell' to talk about the impact of tariffs on small caps.
10 Top Performing European Stocks Heading into 2025
As per Deloitte, inflation in the Eurozone slightly rebounded in October but was still quite low. The consumer price index increased 2% in October as compared to the year earlier.
8 High Growth UK Stocks to Invest In
According to a KPMG report, the United Kingdom’s GDP growth is projected to slow in the second half of 2024 but is expected to rise slightly to 1.2% in 2025.
15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential.
Hedge Fund Resource Center